These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3433525)

  • 1. [Transurethral surgical treatment of invasive bladder tumors (T1 and T2)].
    Wolf H; Iversen HG; Olsen PR; Højgaard K; Schroeder T
    Ugeskr Laeger; 1987 Nov; 149(48):3247-50. PubMed ID: 3433525
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
    Al-Ali MA; Kashmoula DM; Haddad LF
    Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of a second transurethral resection for T1 bladder cancer.
    Schwaibold HE; Sivalingam S; May F; Hartung R
    BJU Int; 2006 Jun; 97(6):1199-201. PubMed ID: 16566814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is repeat transurethral resection needed for minimally invasive T1 urothelial cancer? Pro.
    Herr HW
    J Urol; 2011 Sep; 186(3):787-8. PubMed ID: 21788040
    [No Abstract]   [Full Text] [Related]  

  • 5. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
    Stein JP; Penson DF
    BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of recurrence of T1G3 transitional cell carcinoma of bladder].
    Zhang YS; Li HZ; Zhang RQ; Shi BB
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1305-8. PubMed ID: 16796897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
    Cheng L; Neumann RM; Weaver AL; Cheville JC; Leibovich BC; Ramnani DM; Scherer BG; Nehra A; Zincke H; Bostwick DG
    Am J Clin Pathol; 2000 Feb; 113(2):275-9. PubMed ID: 10664630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
    Hassan JM; Cookson MS; Smith JA; Johnson DL; Chang SS
    J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor.
    Herr HW
    Semin Urol Oncol; 1997 Aug; 15(3):142-6. PubMed ID: 9394908
    [No Abstract]   [Full Text] [Related]  

  • 12. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadiuvant treatment with intravesical interleukin-2 for recurrent superficial transitional bladder carcinoma Ta-T1/G1-2.
    Grasso M; Torelli F; Scannapieco G; Franzoso F; Lania C
    J Immunother; 2001; 24(2):184-7. PubMed ID: 11265776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer.
    Stein JP; Skinner DG
    BJU Int; 2003 Jul; 92(1):12-7. PubMed ID: 12823375
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
    Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
    J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transurethral surgery in the treatment of invasive bladder cancer (T1 and T2).
    Wolf H; Iversen HG; Rosenkilde P; Schrøder T
    Scand J Urol Nephrol Suppl; 1987; 104():127-32. PubMed ID: 3481460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The surgical results in malignant bladder tumors using the Scalpel-1 carbon-dioxide laser].
    Dmitriev BV; Nikol'skiĭ AD; Latyshev MM; Zolin VP; Sanevich RA
    Urol Nefrol (Mosk); 1997; (1):25-8. PubMed ID: 9123661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment for 217 patients with bladder transitional carcinoma].
    Yu SL; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Wang H; Li YH
    Ai Zheng; 2006 Jan; 25(1):73-5. PubMed ID: 16405754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.